Package 70518-0382-5

Brand: lisinopril and hydrochlorothiazide

Generic: lisinopril and hydrochlorothiazide
NDC Package

Package Facts

Identity

Package NDC 70518-0382-5
Digits Only 7051803825
Product NDC 70518-0382
Description

30 TABLET in 1 BLISTER PACK (70518-0382-5)

Marketing

Marketing Status
Marketed Since 2025-06-06
Brand lisinopril and hydrochlorothiazide
Generic lisinopril and hydrochlorothiazide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47f523d7-74ec-451a-e063-6394a90aa13d", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197886"], "spl_set_id": ["3857ac53-0435-4d68-8066-c22291414889"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (70518-0382-5)", "package_ndc": "70518-0382-5", "marketing_start_date": "20250606"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "70518-0382_47f523d7-74ec-451a-e063-6394a90aa13d", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "70518-0382", "generic_name": "Lisinopril and Hydrochlorothiazide", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA077912", "marketing_category": "ANDA", "marketing_start_date": "20170403", "listing_expiration_date": "20271231"}